Recent legislative action on military detention of suspected enemy combatants perpetuates an ambiguity in the law as to whether U.S. citizens may be so detained, a new report from the Congressional Research Service says.
“The circumstances in which a U.S. citizen or other person captured or arrested in the United States may be detained under the authority conferred by the AUMF [the post-9/11 Authorization for Use of Military Force] remains unsettled,” wrote CRS analyst Jennifer Elsea. “The 2012 NDAA [National Defense Authorization Act] does not disturb the state of the law in this regard.”
“Section 1021 [of the NDAA] does not attempt to clarify the circumstances in which a U.S. citizen, resident alien, or other person captured within the United States may be held as an enemy belligerent in the conflict with Al Qaeda. Consequently, if the executive branch decides to hold such a person under the detention authority affirmed in Section 1021, it is left to the courts to decide whether Congress meant to authorize such detention when it enacted the AUMF in 2001,” the CRS report said. See The National Defense Authorization Act for FY2012: Detainee Matters, January 11, 2012.
Some other new CRS reports that have not been made readily available to the public include these:
F-35 Alternate Engine Program: Background and Issues for Congress, January 10, 2011
Horn of Africa Region: The Humanitarian Crisis and International Response, January 6, 2012
Building Civilian Interagency Capacity for Missions Abroad: Key Proposals and Issues for Congress, December 22, 2011
DNA synthesis and export controls remain the primary regulatory safeguards against de novo production of harmful biological agents, yet governance frameworks lack the situational awareness and enforcement capacity to keep pace with rapidly falling technical barriers.
Called today to speak on behalf of U.S. science and technology, Dr. Jedidah Isler, astrophysicist, educator, strategist, policy-maker, and science communicator, will provide constructive, nonpartisan feedback to the House Committee’s hearing “American Global Competitiveness at 250: Legislative Proposals to Secure U.S. Technology Leadership.”
“Federal data and access to it is not a partisan issue. It is a people issue. Our country cannot achieve greatness without access to the data that measure what we value, who we are, and where we’re heading.”
The United States’ biosecurity governance system is structurally incapable of detecting and responding to certain classes of threats. U.S. biosecurity tools have not kept pace with technological advancements or a changing threat landscape.